Home>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>Progesterone

Progesterone (Synonyms: Cyclogest, NSC 9704, NSC 64377)

Catalog No.GC12408


Products are for research use only. Not for human use. We do not sell to patients.

Progesterone Chemical Structure

Cas No.: 57-83-0

Size Price Stock Qty
10mM (in 1mL DMSO)
In stock
In stock
In stock
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product Documents

Quality Control & SDS

View current batch:


Progesterone is a critical hormone for the maintenance of pregnancy, menstrual cycle,  endometrium and functions with its receptor [1].
Progesterone plays an important role in establishing uterine receptivity for embryo implantation. Cooperated with nuclear progesterone receptor, progesterone could damper the action(s) of E2 and BPA on Egr1 expression [2]. When tested with mouse melanoma (B16F10) cells and human melanoma (BLM) cells, progesterone treatment could significantly inhibit mouse melanoma cell growth [3]. In MCF-7 cells, progesterone activated GLI-1 in RANKL dependent manner to regulate estrogen-induced mammary carcinogenesis [4].
When tested with rats (pretreated subcutaneous progesterone or peanut oil for 5 days beginning on pregnancy day 17 and control ones), progesterone (400 and 500 μg per day) treatment enhanced maternal behavior inhibited by opioidergic [1].
Progesterone also has been shown to exhibit neuroprotective effects via modulating the phosphorylation of Akt which plays pivotal role in promoting cell growth in the brain. To assess the effects of progesterone on Akt phosphorylation, when tested with closed-skull traumatic brain injury C57BL/6 mice, after progesterone treatment phosphorylation of Akt in hippocampus increased compared to traumatic brain injury vehicle [5]. When tested with female rats, progesterone treatment asymmetricly modulated the expression of GABA (A) receptor α4 subunit in the olfactory bulb [6].
[1].    Cruz, A.M., M.H. Sukikara, and F.F. L, Late pregnancy progesterone treatment as a modulatory signal for postpartum behavior. Pharmacol Biochem Behav, 2014. 27(14): p. 00348-7.
[2].    Kim, H.R., et al., Egr1 is rapidly and transiently induced by estrogen and bisphenol A via activation of nuclear estrogen receptor-dependent ERK1/2 pathway in the uterus. Reprod Toxicol, 2014. 50: p. 60-7.
[3].    Ramaraj, P. and J.L. Cox, In vitro effect of progesterone on human melanoma (BLM) cell growth. Int J Clin Exp Med, 2014. 7(11): p. 3941-53.
[4].    Boopalan, T., et al., RANKL signaling promotes progesterone mediated estrogen induced mammary carcinogenesis. Cancer Sci, 2014. 21(10): p. 12571.
[5].    Garling, R.J., et al., Does progesterone show neuroprotective effects on traumatic brain injury through increasing phosphorylation of Akt in the hippocampus? Neural Regen Res, 2014. 9(21): p. 1891-6.
[6].    Arbo, B.D., et al., Asymmetric effects of low doses of progesterone on GABA(A) receptor alpha4 subunit protein expression in the olfactory bulb of female rats. Can J Physiol Pharmacol, 2014. 92(12): p. 1045-9.

Chemical Properties

Cas No. 57-83-0 SDF
Synonyms Cyclogest, NSC 9704, NSC 64377
Chemical Name (8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
Formula C21H30O2 M.Wt 314.46
Solubility ≥ 14.65mg/mL in DMSO Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.
  • Molarity Calculator

  • Dilution Calculator

**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).


In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.


Review for Progesterone

Average Rating: 5 ★★★★★ (Based on Reviews and 26 reference(s) in Google Scholar.)

5 Star
4 Star
3 Star
2 Star
1 Star
Review for Progesterone

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.